Peripartum cardiomyopathy

Common Name(s)

Peripartum cardiomyopathy

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Peripartum cardiomyopathy" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Peripartum cardiomyopathy" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Peripartum cardiomyopathy" returned 72 free, full-text research articles on human participants. First 3 results:

Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy.
 

Author(s): A Haghikia, E Podewski, E Libhaber, S Labidi, D Fischer, P Roentgen, D Tsikas, J Jordan, R Lichtinghagen, C S von Kaisenberg, I Struman, N Bovy, K Sliwa, J Bauersachs, Denise Hilfiker-Kleiner

Journal: Basic Res. Cardiol.. 2013 Jul;108(4):366.

 

Peripartum cardiomyopathy (PPCM) is a life-threatening heart disease developing towards the end of pregnancy or in the months following delivery in previously healthy women in terms of cardiac disease. Enhanced oxidative stress and the subsequent cleavage of the nursing hormone Prolactin ...

Last Updated: 1 Jul 2013

Go To URL
MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy.
 

Author(s): Julie Halkein, Sebastien P Tabruyn, Melanie Ricke-Hoch, Arash Haghikia, Ngoc-Quynh-Nhu Nguyen, Michaela Scherr, Karolien Castermans, Ludovic Malvaux, Vincent Lambert, Marc Thiry, Karen Sliwa, Agnes Noel, Joseph A Martial, Denise Hilfiker-Kleiner, Ingrid Struman

Journal: J. Clin. Invest.. 2013 May;123(5):2143-54.

 

Peripartum cardiomyopathy (PPCM) is a life-threatening pregnancy-associated cardiomyopathy in previously healthy women. Although PPCM is driven in part by the 16-kDa N-terminal prolactin fragment (16K PRL), the underlying molecular mechanisms are poorly understood. We found that 16K ...

Last Updated: 2 May 2013

Go To URL
A microRNA links prolactin to peripartum cardiomyopathy.
 

Author(s): Ying Yang, Jessica E Rodriguez, Richard N Kitsis

Journal: J. Clin. Invest.. 2013 May;123(5):1925-7.

 

For decades, peripartum cardiomyopathy has remained an enigma. Despite extensive research, our understanding of how a previously healthy woman can develop lethal heart failure in the context of pregnancy remains vague. Recent work suggests that inadequacy of the cardiac microvasculature ...

Last Updated: 2 May 2013

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Peripartum cardiomyopathy" returned 11 free, full-text review articles on human participants. First 3 results:

Peripartum cardiomyopathy: moving towards a more central role of genetics.
 

Author(s): Roberto Cemin, Rajesh Janardhanan, Luca Donazzan, Massimo Daves

Journal: Curr Cardiol Rev. 2013 Aug;9(3):179-84.

 

Peripartum cardiomyopathy (PCM) is a relatively rare disease with potentially devasting consequences requiring prompt identification and correct treatment. Overall prognosis is good in majority of the cases, although some patients may progress to irreversible heart failure. Early ...

Last Updated: 19 Aug 2013

Go To URL
Cardiology patient page: peripartum cardiomyopathy.
 

Author(s): Michael M Givertz

Journal: Circulation. 2013 May;127(20):e622-6.

 

Last Updated: 21 May 2013

Go To URL
Peripartum cardiomyopathy: a contemporary review.
 

Author(s): Tina Shah, Sameer Ather, Chirag Bavishi, Arvind Bambhroliya, Tony Ma, Biykem Bozkurt

Journal: Methodist Debakey Cardiovasc J. ;9(1):38-43.

 

Peripartum cardiomyopathy is a rare and potentially fatal disease. Though approximately half of the patients recover, the clinical course is highly variable and some patients develop refractory heart failure and persistent left ventricular systolic dysfunction. It is diagnosed when ...

Last Updated: 22 Mar 2013

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Effect of Bromocriptine on Left Ventricular Function in Women With Peripartum Cardiomyopathy
 

Status: Recruiting

Condition Summary: Peripartum Cardiomyopathy

 

Last Updated: 12 Sep 2012

Go to URL
Registry and Survey of Women With Pregnancy Related Cardiomyopathy
 

Status: Recruiting

Condition Summary: Cardiomyopathy; Pregnancy-Associated Cardiomyopathy; Heart Failure

 

Last Updated: 25 May 2006

Go to URL